Health Value proposition
[Automatic translation follows] Prevention / Care / Research / Education, at the service of patients with #cancer.
Gustave Roussy, the leading cancer center in Europe, the 4th best cancer hospital in the world, is a global center of expertise against cancer, at the service of patients.
It brings together 3,100 professionals whose missions are prevention, care, research and education on two sites: in Villejuif and Chevilly-Larue (Greater Paris).
A private institution of collective interest, Gustave Roussy is authorized to receive donations and legacies.
Cancerology, care, research, and educationOriginal language
Prévention / Soins / Recherche / Enseignement, au service des patients atteints de #cancer.
Gustave Roussy, premier centre de lutte contre le cancer en Europe, 4e meilleur hôpital de cancérologie au monde, constitue un pôle d’expertise global contre le cancer, au service des patients.
Il réunit 3 100 professionnels dont les missions sont la prévention, le soin, la recherche et l’éducation sur deux sites : à Villejuif et à Chevilly-Larue (Grand Paris).
Etablissement privé d'intérêt collectif, Gustave Roussy est habilité à recevoir des dons et des legs.
Cancérologie, soins, recherche, and enseignement
Gustave Roussy | 1er centre de lutte contre le cancer en Europe
Gustave Roussy | 1er centre de lutte contre le cancer en Europe
https://www.gustaveroussy.fr/
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Loccioni it services | Other 6 Feb 2024 | | |
 | American Society of Clinical Oncology (ASCO) healthtech | Other 18 Jul 2024 | | |
 | CyberCamp Santé healthtech | Other 30 Jan 2024 | | |
 | Collectif Triplettes Roses healthtech | Other 27 Sep 2024 | | |
 | FONDATION SANTE SERVICE healthtech | Other 6 Feb 2024 | | |
 | SURPHAM sarl deeptech, healthtech, Medical Equipment Manufacturing | Other 16 May 2023 | | |
 | CMA IDF - Val-de-Marne Government Administration | Other 12 Feb 2024 | | |
 | CERN it services, Research Services | Other 4 Feb 2024 | | |
 | L'Obs Newspaper Publishing | Other 8 Feb 2024 | | |
 | EverImmune biotech, deeptech | Other 31 Jul 2023 | | |